News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GTC Biotherapeutics (GTCB) Reports Third Quarter 2010 Financial Results



10/28/2010 12:41:59 PM

FRAMINGHAM, Mass.--(BUSINESS WIRE)--In the Selected Financial Information, under Net income (loss) per common share - Diluted, the Three Months Ended September 30, 2010 should read: $0.05 (sted $0.39). Under Weighted average number of shares outstanding - Diluted, the Three Months Ended September 30, 2010 should read: 77,670 (sted 8,943).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES